WEBINAR
Tuesday, April 28, 9:00 AM PDT | 12:00 PM EDT | 5:00 PM BST
Thursday, April 30, 10:00 AM SGT | 12:00 PM AEST
Gene editing using CRISPR-Cas9 or similar systems is foundational in many gene therapies. The repair of CRISPR-Cas9 induced double-strand breaks can produce a wide range of outcomes, including small to larger indels of up to several kbs, as well as integration of template constructs at target sites. Accurately characterizing these events is critical in research and drug development.
Short-read sequencing can miss important information such as longer insertions and deletions, or structural variations like chromosomal rearrangements. In addition, commonly used amplification-based methods may introduce unintended biases.
In this webinar, we’ll introduce how highly accurate HiFi long-read sequencing enables a more complete, unbiased view of gene editing outcomes. You’ll learn how amplification-free workflows, such as PureTarget, can capture on- and off-target edits—including larger and more complex events—without the limitations of PCR-based methods.
Register to:
SAVE YOUR SEAT

Nadia Sellami, PhD
Global Lead, Biopharma, PacBio

Adam Ameur, PhD
Associate Professor and Senior Bioinformatician, SciLifeLab National Genomics Infrastructure, Uppsala University, Sweden